163 related articles for article (PubMed ID: 38062162)
1. Treatment for Gorham-Stout syndrome with a combination of teriparatide and denosumab.
Zhang L; Wang W; Wen L; Xue F; Li J; Qian Y
Osteoporos Int; 2024 Apr; 35(4):727-731. PubMed ID: 38062162
[TBL] [Abstract][Full Text] [Related]
2. Gorham-Stout Syndrome of the Shoulder Girdle Successfully Controlled by Antiresorptive Agents: A Report of 2 Cases.
Matsumoto T; Naito M; Hirose J; Nakada I; Morikawa T; Tanaka S
JBJS Case Connect; 2019; 9(2):e0285. PubMed ID: 31211750
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of Gorham-Stout syndrome in the spine by vertebroplasty with cement augmentation: A case report and literature review.
Liu S; Zhou X; Song A; Kong X; Wang Y; Liu Y
Medicine (Baltimore); 2018 Jul; 97(29):e11555. PubMed ID: 30024550
[TBL] [Abstract][Full Text] [Related]
4. Gorham-Stout Disease: Hand Involvement in an 8-Year-Old Child.
Klein C; Haraux E; Gouron R
J Pediatr; 2017 Dec; 191():277-277.e1. PubMed ID: 28964427
[No Abstract] [Full Text] [Related]
5. [Gorham-Stout idiopathic osteolysis--a local osteoclastic hyperactivity?].
Möller G; Gruber H; Priemel M; Werner M; Kuhlmey AS; Delling G
Pathologe; 1999 May; 20(3):177-82. PubMed ID: 10412177
[TBL] [Abstract][Full Text] [Related]
6. The Gorham-Stout syndrome (Gorham's massive osteolysis). A report of six cases with histopathological findings.
Möller G; Priemel M; Amling M; Werner M; Kuhlmey AS; Delling G
J Bone Joint Surg Br; 1999 May; 81(3):501-6. PubMed ID: 10872375
[TBL] [Abstract][Full Text] [Related]
7. Gorham-Stout Syndrome: A Phantom Bone Disease Treated With Bisphosphonates.
Elera-Fitzcarrald C; Ugarte-Gil MF
J Clin Rheumatol; 2020 Aug; 26(5):e135-e136. PubMed ID: 30801337
[No Abstract] [Full Text] [Related]
8. Propranolol as a treatment option in Gorham-Stout syndrome: a case report.
Nir V; Guralnik L; Livnat G; Bar-Yoseph R; Hakim F; Ilivitzki A; Bentur L
Pediatr Pulmonol; 2014 Apr; 49(4):417-9. PubMed ID: 24000203
[TBL] [Abstract][Full Text] [Related]
9. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
[TBL] [Abstract][Full Text] [Related]
10. A case of restitution ad integrum in Gorham-Stout disease.
Pickering ME; Gensburger D; Chapurlat R; Rieu V; Chevenet C; Tournadre A; Perrey A; Ltaief-Boudrigua A
Joint Bone Spine; 2023 Jan; 90(1):105478. PubMed ID: 36332892
[TBL] [Abstract][Full Text] [Related]
11. Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature.
Liu Y; Zhong DR; Zhou PR; Lv F; Ma DD; Xia WB; Jiang Y; Wang O; Xing XP; Li M
Clin Rheumatol; 2016 Mar; 35(3):813-23. PubMed ID: 25227772
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.
Lyu H; Zhao SS; Yoshida K; Tedeschi SK; Xu C; Nigwekar SU; Leder BZ; Solomon DH
J Clin Endocrinol Metab; 2019 Nov; 104(11):5611-5620. PubMed ID: 31265071
[TBL] [Abstract][Full Text] [Related]
13. Difficult Therapeutic Decisions in Gorham-Stout Disease-Case Report and Review of the Literature.
Wojciechowska-Durczynska K; Zygmunt A; Mikulak M; Ludwisiak M; Lewinski A
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141975
[TBL] [Abstract][Full Text] [Related]
14. Gorham-Stout Syndrome with chylothorax: successful remission by interferon alpha-2b.
Kose M; Pekcan S; Dogru D; Akyuz C; Ozcelik U; Ozsurekci Y; Gulhan B; Demircin M; Kiper N
Pediatr Pulmonol; 2009 Jun; 44(6):613-5. PubMed ID: 19434689
[TBL] [Abstract][Full Text] [Related]
15. Could local deliver of bisphosphonates be a new therapeutic choice for Gorham-Stout syndrome?
Sun S; Liu X; Ma B; Zhou Y; Sun H
Med Hypotheses; 2011 Feb; 76(2):237-8. PubMed ID: 21044823
[TBL] [Abstract][Full Text] [Related]
16. Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.
Ebina K; Hirao M; Hashimoto J; Matsuoka H; Iwahashi T; Chijimatsu R; Etani Y; Okamura G; Miyama A; Yoshikawa H
Osteoporos Int; 2018 Jul; 29(7):1627-1636. PubMed ID: 29574517
[TBL] [Abstract][Full Text] [Related]
17. Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome.
Lehmann G; Pfeil A; Böttcher J; Kaiser WA; Füller J; Hein G; Wolf G
Arch Orthop Trauma Surg; 2009 Jul; 129(7):967-72. PubMed ID: 18807053
[TBL] [Abstract][Full Text] [Related]
18. Gorham-Stout syndrome, the challenge in diagnosis and unique in treatment: a case report.
Saberi S; Bagheri N; Kalantar SH; Saffar H; Khabiri SS
J Med Case Rep; 2023 Aug; 17(1):360. PubMed ID: 37605280
[TBL] [Abstract][Full Text] [Related]
19. Gorham-Stout syndrome: a rare clinical entity and review of literature.
Gondivkar SM; Gadbail AR
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):e41-8. PubMed ID: 19969488
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: a novel clue to the pathogenesis of a rare syndrome.
Bruch-Gerharz D; Gerharz CD; Stege H; Krutmann J; Pohl M; Koester R; Ruzicka T
J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S21-5. PubMed ID: 17097379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
